Literature DB >> 28460313

BF2-azadipyrromethene NIR-emissive fluorophores with research and clinical potential.

Harrison C Daly1, Gonzalo Sampedro1, Corentin Bon1, Dan Wu1, Ghazi Ismail2, Ronan A Cahill2, Donal F O'Shea3.   

Abstract

The use of near-infrared fluorescence for in vivo research and intraoperative clinical imaging is rapidly expanding, with new applications being proposed and developed. While imaging hardware and software have significantly progressed in recent times, the molecular fluorescent agents remain a limiting factor. In this report, the design, synthesis, photophysical characterization and bio-medical imaging assessment of two new NIR-fluorophores based on the BF2-azadipyrromethene fluorophore class are described. Inclusion of dimethylamino substituents on these BF2-azadipyrromethene probes results in very large bathochromic shifts with photophysical measurements showing absorption and emission maxima between 757 and 818 nm within the desired NIR spectra region. Testing of the probes shows that they are suitable for fluorescence imaging with both research and clinical instrumentation. Preclinical imaging assessment shows their suitability as fluorescent markers (tattoos) of lesions for intraoperative identification and lymphatic mapping in ex vivo human colonic tissue. These new clinical wavelength-compatible fluorophores may contribute towards the on-going expansion of medical uses for NIR-fluorescence.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fluorescence guided surgery; Lymph node; NIR-fluorescence; Tattoo

Mesh:

Substances:

Year:  2017        PMID: 28460313     DOI: 10.1016/j.ejmech.2017.04.051

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

Review 1.  Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents.

Authors:  Oluwakanyinsolami Netufo; Kate Connor; Liam P Shiels; Kieron J Sweeney; Dan Wu; Donal F O'Shea; Annette T Byrne; Ian S Miller
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-29

2.  Digital dynamic discrimination of primary colorectal cancer using systemic indocyanine green with near-infrared endoscopy.

Authors:  Jeffrey Dalli; Eamon Loughman; Niall Hardy; Anwesha Sarkar; Mohammad Faraz Khan; Haseeb A Khokhar; Paul Huxel; Donal F O'Shea; Ronan A Cahill
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

3.  Aza-BODIPY based polymeric nanoparticles for cancer cell imaging.

Authors:  Kantapat Chansaenpak; Similan Tanjindaprateep; Nipha Chaicharoenaudomrung; Oratai Weeranantanapan; Parinya Noisa; Anyanee Kamkaew
Journal:  RSC Adv       Date:  2018-11-23       Impact factor: 3.361

4.  Multicentre phase II trial of near-infrared imaging in elective colorectal surgery.

Authors:  F Ris; E Liot; N C Buchs; R Kraus; G Ismael; V Belfontali; J Douissard; C Cunningham; I Lindsey; R Guy; O Jones; B George; P Morel; N J Mortensen; R Hompes; R A Cahill
Journal:  Br J Surg       Date:  2018-04-16       Impact factor: 6.939

5.  Linker length in fluorophore-cholesterol conjugates directs phase selectivity and cellular localisation in GUVs and live cells.

Authors:  Darragh O' Connor; Aisling Byrne; Tia E Keyes
Journal:  RSC Adv       Date:  2019-07-23       Impact factor: 4.036

6.  Directed self-assembly of fluorescence responsive nanoparticles and their use for real-time surface and cellular imaging.

Authors:  Shane Cheung; Donal F O'Shea
Journal:  Nat Commun       Date:  2017-12-01       Impact factor: 14.919

7.  RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery.

Authors:  Dan Wu; Harrison C Daly; Marco Grossi; Emer Conroy; Bo Li; William M Gallagher; Robert Elmes; Donal F O'Shea
Journal:  Chem Sci       Date:  2019-06-21       Impact factor: 9.825

8.  An EPR Strategy for Bio-responsive Fluorescence Guided Surgery with Simulation of the Benefit for Imaging.

Authors:  Harrison C Daly; Emer Conroy; Mihai Todor; Dan Wu; William M Gallagher; Donal F O'Shea
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.